LAVA Therapeutics (LVTX) Earnings Date, Estimates & Call Transcripts $1.31 +0.01 (+0.77%) As of 01:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LAVA Therapeutics Earnings Summary LAVA Therapeutics released Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.13, which beat analysts' consensus estimates of -$0.37 by $0.24. With a trailing EPS of -$1.04, LAVA Therapeutics' earnings are expected to decrease next year, from ($1.13) to ($1.30) per share. Upcoming Q2 Earnings DateAug. 19Before Market OpensEstimatedConsensus EPS (May. 14) -$0.37 Actual EPS (May. 14) -$0.13 Beat By $0.24 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)LVTX Upcoming EarningsLAVA Therapeutics' next earnings date is estimated for Tuesday, August 19, 2025, based on past reporting schedules. Powered by Get LAVA Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LAVA Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. LAVA Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.40-$0.23-$0.32Q2 20252-$0.38-$0.23-$0.31Q3 20252-$0.35-$0.22-$0.29Q4 20252-$0.33-$0.23-$0.28 FY 2025 8 -$1.46 -$0.91 -$1.19 Q1 20261-$0.21-$0.21-$0.21Q2 20261-$0.20-$0.20-$0.20Q3 20261-$0.19-$0.19-$0.19Q4 20261-$0.06-$0.06-$0.06 LAVA Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/19/2025(Estimated)--------5/14/2025Q1 2025-$0.37-$0.13+$0.24-$0.13--3/28/2025Q4 2024-$0.32-$0.14+$0.18-$0.14$2.40M$2.50M12/10/2024Q3 2024-$0.35-$0.46 -$0.11-$0.46--8/20/2024Q2 2024-$0.36-$0.31+$0.05-$0.31--5/21/2024Q1 2024-$0.25-$0.02+$0.23-$0.02-$6.99M3/20/2024Q4 2023$0.16-$0.24 -$0.40-$0.24$25.00M$0.35M11/16/2023Q3 2023-$0.49-$0.34+$0.15-$0.34-$0.05M8/22/2023Q2 2023-$0.50-$0.48+$0.02-$0.48$2.50M$5.14M LAVA Therapeutics Earnings - Frequently Asked Questions When is LAVA Therapeutics' earnings date? LAVA Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 19th, 2025 based off last year's report dates. Learn more on LVTX's earnings history. Did LAVA Therapeutics beat their earnings estimates last quarter? In the previous quarter, LAVA Therapeutics (NASDAQ:LVTX) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.24. Learn more on analysts' earnings estimate vs. LVTX's actual earnings. How much revenue does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded annual revenue of $11.98 million. How much profit does LAVA Therapeutics generate each year? LAVA Therapeutics (NASDAQ:LVTX) has a recorded net income of -$25.11 million. LVTX has generated -$1.04 earnings per share over the last four quarters. What is LAVA Therapeutics' EPS forecast for next year? LAVA Therapeutics' earnings are expected to decrease from ($1.13) per share to ($1.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies FitLife Brands Earnings Date Nkarta Earnings Date Greenwich LifeSciences Earnings Date Protara Therapeutics Earnings Date TuHURA Biosciences Earnings Date Protalix BioTherapeutics Earnings Date Cabaletta Bio Earnings Date Theratechnologies Earnings Date C4 Therapeutics Earnings Date Atossa Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:LVTX) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe stealth altcoin the financial world is underestimatingWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s End Game Is Going Live -- And It Could Make You a FortuneThe media and the so-called experts have laughed at Elon Musk his entire career. CBS called PayPal “one of ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredThe Dollar Reset Nobody’s Talking AboutCould this man take down the financial system? In March, the Senate granted sweeping powers to a Harvard ec...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LVTX Stock Free LVTX Stock Alerts